OPT Bathi saben saham sajrone rolas wulan pungkasan Opthea Ltd.

Massive demand for macular degeneration therapy is being constrained by uncertainty surrounding final drug trials, creating risks for capitalization. The TTM EPS dynamics for Opthea Limited (OPT) are recorded at -2.33 on this GURU.Markets platform chart. Business stability is ensured by competent Australian management, which demonstrates full research transparency and an ability to attract global partners in ophthalmology.

OPT Bathi resik saben siji saham sajrone rolas wulan pungkasan Opthea Limited (04.07.2022 - 28.06.2025)

Opthea Ltd (OPT) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:

Rega saham Opthea Limited|OPT - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Opthea Limited|OPT - Rega Tumbas Perusahaan

- data nilai buku modal saham:

Aset Bersih saben Siji Saham Opthea|OPT - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku opthea.com|OPT - Nilai Total Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

- data bathi lan kelipatan valuasi:

OPT - Bathi pungkasan|Bathi sing dikarepake Opthea Limited|OPT - Rasio rega marang bathi|Pangali Forward P/E Opthea|OPT - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Opthea Limited|OPT - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Opthea|OPT - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan opthea.com|OPT - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Opthea Limited

Analisis umum perusahaan:Opthea Limited (OPT)

For Opthea Limited (OPT), EPS becomes a key indicator of capitalization efficiency amid fierce competition with ophthalmology giants. This metric is calculated by dividing the total annual net income by the total number of shares. By analyzing the EPS trend over the last 12 months, an investor assesses the real return on each share of ownership. This price action reflects the company's ability to generate profit despite pressure from blockbuster competitors. Steady growth confirms the viability of the business model.

Pesaing utama

Alcon Inc. - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan bausch.com|Glaukos (GKOS) - Bathi saben saham sajrone rolas wulan pungkasan|APLS - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Belite Bio, Inc|Bathi resik saben siji saham sajrone rolas wulan pungkasan Ocular Pharma OCUL|Bathi saben saham sajrone rolas wulan pungkasan Harrow, Inc. (HROW)|VRDN: Bathi saben siji saham sajrone 12 wulan pungkasan|LENZ Therapeutics - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan OCS (Oculis AG)|EyePoint Pharma - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajroning taun lumaku KOD (Kodiak Corp)|ALDX: Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan KALA BIO (KALA)|IRD (Opus Genetics, Inc.) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) OKYO Pharma Inc|Bathi resik saben saham sajrone 12 wulan pungkasan ADVM (Adverum Biotechnologies)|OTLK (Outlook Therapeutics Corp) - Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan Clearside Biomedical CLSD|NovaBay Pharmaceuticals Inc. - Bathi saben saham sajrone rolas wulan pungkasan|Kiora Pharma - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan Alimera Sciences ALIM|eyenovia.com (EYEN) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan Guardion Health|OCUP (Ocuphire Pharma, Inc.) - Bathi resik saben saham (EPS TTM)